Akebia Therapeutics Inc (AKBA)
1.80
+0.01
(+0.56%)
USD |
NASDAQ |
Nov 18, 16:00
1.80
0.00 (0.00%)
Pre-Market: 08:29
Akebia Therapeutics Max Drawdown (5Y): 98.40% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.40% |
| September 30, 2024 | 98.40% |
| August 31, 2024 | 98.40% |
| July 31, 2024 | 98.40% |
| June 30, 2024 | 98.40% |
| May 31, 2024 | 98.40% |
| April 30, 2024 | 98.40% |
| March 31, 2024 | 98.40% |
| February 29, 2024 | 98.40% |
| January 31, 2024 | 98.40% |
| December 31, 2023 | 98.40% |
| November 30, 2023 | 98.40% |
| October 31, 2023 | 98.40% |
| September 30, 2023 | 98.40% |
| August 31, 2023 | 98.40% |
| July 31, 2023 | 98.40% |
| June 30, 2023 | 98.40% |
| May 31, 2023 | 98.40% |
| April 30, 2023 | 98.40% |
| March 31, 2023 | 98.40% |
| February 28, 2023 | 98.40% |
| January 31, 2023 | 98.40% |
| December 31, 2022 | 98.40% |
| November 30, 2022 | 98.40% |
| October 31, 2022 | 98.39% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.39% |
| August 31, 2022 | 98.39% |
| July 31, 2022 | 98.39% |
| June 30, 2022 | 98.39% |
| May 31, 2022 | 98.39% |
| April 30, 2022 | 97.89% |
| March 31, 2022 | 96.35% |
| February 28, 2022 | 91.15% |
| January 31, 2022 | 90.70% |
| December 31, 2021 | 88.71% |
| November 30, 2021 | 88.71% |
| October 31, 2021 | 88.71% |
| September 30, 2021 | 88.71% |
| August 31, 2021 | 88.71% |
| July 31, 2021 | 88.71% |
| June 30, 2021 | 88.71% |
| May 31, 2021 | 88.71% |
| April 30, 2021 | 88.71% |
| March 31, 2021 | 88.71% |
| February 28, 2021 | 88.71% |
| January 31, 2021 | 88.71% |
| December 31, 2020 | 88.71% |
| November 30, 2020 | 88.71% |
| October 31, 2020 | 88.71% |
| September 30, 2020 | 87.85% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.21%
Minimum
Nov 2019
98.40%
Maximum
Nov 2022
93.14%
Average
98.14%
Median
Max Drawdown (5Y) Benchmarks
| Corcept Therapeutics Inc | 60.35% |
| Eli Lilly and Co | 22.48% |
| Bioventus Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.87 |
| Beta (5Y) | 0.7402 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 108.4% |
| Historical Sharpe Ratio (5Y) | -0.1597 |
| Historical Sortino (5Y) | -0.27 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.87% |